Breaking News

RBS First-Half Profit Doubles, Shares Gain as Much as 10% in London
Tweet TWEET

MYCENAX BIOTECH February Sales Fall 81.19% (Table) : 4726 TT

MYCENAX BIOTECH said unconsolidated sales in February fell 81.19% to NT$85,000 from NT$452,000, according to a statement filed to the Taiwan Stock Exchange.

(Figures are in thousands of New Taiwan dollars)

=================================================================

2/2012 2/2011 Sales 85 452 YOY% -81.19%

-----------------Year-to-date----------------- Sales 2,497 553 YOY% 351.54% =================================================================

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.